MedPath
NMPA Approval

Nirmatrelvir Tablets/Ritonavir Tablets(co-packaged)

国药准字HJ20220006

February 11, 2022

Drug Information

奈玛特韦片/利托那韦片组合包装

瑞派乐

片剂

奈玛特韦片150mg/利托那韦片100mg

化学药品

February 11, 2022

February 10, 2026

Company Information

Applicant Company

PFIZER LIMITED

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Manufacturing Company

组合包装中奈玛特韦片企业名称:pfizer manufacturing deutschland gmbh;组合包装中利托那韦片企业名称:hetero labs limited

组合包装中奈玛特韦片生产地址:Betriebsstaette Freiburg, Mooswaldallee 1, Freiburg, D-79090, Germany;组合包装中利托那韦片生产地址:Unit III, 22-110, Industrial Development Area, Jeedimetla, Hyderabad, Telangana, In-500 055, India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奈玛特韦片/利托那韦片组合包装 - NMPA 批准文号 | MedPath